An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms.
Zhang N, Zhang H, Liu Z, Dai Z, Wu W, Zhou R, Li S, Wang Z, Liang X, Wen J, Zhang X, Zhang B, Ouyang S, Zhang J, Luo P, Li X, Cheng Q.
Zhang N, et al. Among authors: zhang b, zhang j, zhang h, zhang x.
Cell Prolif. 2023 Apr;56(4):e13409. doi: 10.1111/cpr.13409. Epub 2023 Feb 23.
Cell Prolif. 2023.
PMID: 36822595
Free PMC article.